In this study, we observed that hnRNP-L upregulated p-ERK, p-p38 and p-JNK suggesting that hnRNP-L regulated cell fate in bladder cancer cells by promoting the MAPK (ERK/JNK/p38MAPK) signaling pathway. The gene discussed is HNRNPL; the disease is urinary bladder cancer.